Nuvation Bio Inc.
NUVB
$2.18
$0.020.93%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 142.64% | 59.17% | 19.45% | -12.53% | -10.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 501.57% | 443.60% | 407.11% | -20.81% | -16.63% |
| Operating Income | -493.68% | -441.51% | -405.76% | 20.81% | 16.63% |
| Income Before Tax | -649.24% | -542.39% | -464.87% | 34.18% | 27.25% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -649.24% | -542.39% | -464.87% | 34.18% | 27.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -649.24% | -542.39% | -464.87% | 34.18% | 27.25% |
| EBIT | -493.68% | -441.51% | -405.76% | 20.81% | 16.63% |
| EBITDA | -494.32% | -442.14% | -406.41% | 20.86% | 16.68% |
| EPS Basic | -551.03% | -473.22% | -410.13% | 34.51% | 27.96% |
| Normalized Basic EPS | -552.06% | -475.20% | -412.99% | 33.84% | 27.21% |
| EPS Diluted | -551.03% | -473.22% | -410.13% | 34.51% | 27.96% |
| Normalized Diluted EPS | -552.06% | -475.20% | -412.99% | 33.84% | 27.21% |
| Average Basic Shares Outstanding | 22.70% | 9.29% | 3.13% | 0.42% | 1.00% |
| Average Diluted Shares Outstanding | 22.70% | 9.29% | 3.13% | 0.42% | 1.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |